EGFR and neoplasm: There is conflicting data regarding the impact of EGFR status on PD-L1 expression levels—with some analyses suggesting that PD-L1 expression may be inherently reduced in EGFR-mutant tumours, whilst others describe no correlation, or even the opposite effect (7, 107, 113, 114).